Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response
- PMID: 22009685
- DOI: 10.1002/eji.201141825
Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response
Abstract
High macrophage infiltration into tumours often correlates with poor prognoses; in colorectal, stomach and skin cancers, however, the opposite is observed but the mechanisms behind this phenomenon remain unclear. Here, we sought to understand how tumour-associated macrophages (TAMs) in colorectal cancer execute tumour-suppressive roles. We found that TAMs in a colorectal cancer model were pro-inflammatory and inhibited the proliferation of tumour cells. TAMs also produced chemokines that attract T cells, stimulated proliferation of allogeneic T cells and activated type-1 T cells associated with anti-tumour immune responses. Using colorectal tumour tissues, we verified that TAMs in vivo were indeed pro-inflammatory. Furthermore, the number of tumour-infiltrating T cells correlated with the number of TAMs, suggesting that TAMs could attract T cells; and indeed, type-1 T cells were present in the tumour tissues. Patient clinical data suggested that TAMs exerted tumour-suppressive effects with the help of T cells. Hence, the tumour-suppressive mechanisms of TAMs in colorectal cancer involve the inhibition of tumour cell proliferation alongside the production of pro-inflammatory cytokines, chemokines and promoting type-1 T-cell responses. These new findings would contribute to the development of future cancer immunotherapies based on enhancing the tumour-suppressive properties of TAMs to boost anti-tumour immune responses.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824. Epub 2008 Nov 20. Gut. 2009. PMID: 19022917
-
Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.J Pathol. 2011 Feb;223(3):347-57. doi: 10.1002/path.2819. Epub 2010 Dec 10. J Pathol. 2011. PMID: 21171080
-
The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.Cancer Treat Rev. 2012 Aug;38(5):451-66. doi: 10.1016/j.ctrv.2011.09.001. Epub 2011 Sep 25. Cancer Treat Rev. 2012. PMID: 21945823 Review.
-
Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.Cancer Res. 2011 Feb 15;71(4):1263-71. doi: 10.1158/0008-5472.CAN-10-2907. Epub 2011 Feb 8. Cancer Res. 2011. PMID: 21303976
-
Tumor-associated macrophages in skin: How to treat their heterogeneity and plasticity.J Dermatol Sci. 2016 Sep;83(3):167-73. doi: 10.1016/j.jdermsci.2016.05.015. Epub 2016 May 25. J Dermatol Sci. 2016. PMID: 27291068 Review.
Cited by
-
Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development.Theranostics. 2018 Oct 22;8(19):5259-5275. doi: 10.7150/thno.29098. eCollection 2018. Theranostics. 2018. PMID: 30555545 Free PMC article. Review.
-
The Prognosis of Cancer Depends on the Interplay of Autophagy, Apoptosis, and Anoikis within the Tumor Microenvironment.Cell Biochem Biophys. 2023 Dec;81(4):621-658. doi: 10.1007/s12013-023-01179-4. Epub 2023 Oct 3. Cell Biochem Biophys. 2023. PMID: 37787970 Review.
-
Data Driven Mathematical Model of FOLFIRI Treatment for Colon Cancer.Cancers (Basel). 2021 May 27;13(11):2632. doi: 10.3390/cancers13112632. Cancers (Basel). 2021. PMID: 34071939 Free PMC article.
-
Prognostic Role of CD68+ and CD163+ Tumour-Associated Macrophages and PD-L1 Expression in Oral Squamous Cell Carcinoma: A Meta-Analysis.Br J Biomed Sci. 2023 Jun 16;80:11065. doi: 10.3389/bjbs.2023.11065. eCollection 2023. Br J Biomed Sci. 2023. PMID: 37397243 Free PMC article.
-
Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets.Int J Mol Sci. 2016 Nov 23;17(11):1958. doi: 10.3390/ijms17111958. Int J Mol Sci. 2016. PMID: 27886105 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases